APA (7th ed.) Citation

Marcellin, P., Martinot-Peignoux, M., Lau, G., Liaw, Y., Messinger, D., Rothe, V., . . . Asselah, T. (2014). P697 SERUM LEVELS OF HEPATITIS B SURFACE ANTIGEN (HBsAg) PREDICT HEPATIC FIBROSIS SEVERITY IN E ANTIGEN-POSITIVE CHRONIC HEPATITIS B (HBeAg+VE CHB) PATIENTS. Journal of Hepatology, 60, S301. https://doi.org/10.1016/S0168-8278(14)60859-X

Chicago Style (17th ed.) Citation

Marcellin, P., M. Martinot-Peignoux, G. Lau, Y.-F Liaw, D. Messinger, V. Rothe, R. Batrla, and T. Asselah. "P697 SERUM LEVELS OF HEPATITIS B SURFACE ANTIGEN (HBsAg) PREDICT HEPATIC FIBROSIS SEVERITY IN E ANTIGEN-POSITIVE CHRONIC HEPATITIS B (HBeAg+VE CHB) PATIENTS." Journal of Hepatology 60 (2014): S301. https://doi.org/10.1016/S0168-8278(14)60859-X.

MLA (9th ed.) Citation

Marcellin, P., et al. "P697 SERUM LEVELS OF HEPATITIS B SURFACE ANTIGEN (HBsAg) PREDICT HEPATIC FIBROSIS SEVERITY IN E ANTIGEN-POSITIVE CHRONIC HEPATITIS B (HBeAg+VE CHB) PATIENTS." Journal of Hepatology, vol. 60, 2014, p. S301, https://doi.org/10.1016/S0168-8278(14)60859-X.